|
|
Previous Article | Table of Contents | Next Article 
Role of light chain variable region in myeloma with light chain deposition
disease: evidence from an experimental model
AA Khamlichi, A Rocca, G Touchard, P Aucouturier, JL Preud'homme and M Cogne
Laboratoire d'Immunologie et Genetique, CNRS URA 1172, IBMIG, Faculte des
Sciences, Poitiers, France.
Light chain deposition disease (LCDD) results from a propensity of some
human monoclonal L chains to form tissue deposits. We designed an
experimental model for in vivo expression of human kappa L chain sequences
in mice and compared a somatically mutated LCDD chain with a closely
related control kappa chain, both encoded by the unique V kappa IV gene.
Mice secreting the LCDD chain but not those producing the control chain
showed deposits with a distribution similar to that observed in patients.
These data show that discrete changes in V region sequences can play a
major role in tissue deposition of human L chains.
Volume 86,
Issue 10,
pp. 3655-3659,
11/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Ronco, E. Plaisier, B. Mougenot, and P. Aucouturier
Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy
Clin. J. Am. Soc. Nephrol.,
November 1, 2006;
1(6):
1342 - 1350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Merlini and M. J. Stone
Dangerous small B-cell clones
Blood,
October 15, 2006;
108(8):
2520 - 2530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sirac, F. Bridoux, C. Carrion, O. Devuyst, B. Fernandez, J.-M. Goujon, C. E. Hamel, J.-C. Aldigier, G. Touchard, and M. Cogne
Role of the monoclonal {kappa} chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome
Blood,
July 15, 2006;
108(2):
536 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Decourt, H. R. Galea, C. Sirac, and M. Cogne
Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias
J. Leukoc. Biol.,
September 1, 2004;
76(3):
528 - 536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. RONCO, M.-A. ALYANAKIAN, B. MOUGENOT, and P. AUCOUTURIER
Light Chain Deposition Disease: A Model of Glomerulosclerosis Defined at the Molecular Level
J. Am. Soc. Nephrol.,
July 1, 2001;
12(7):
1558 - 1565.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Decourt, A. Rocca, F. Bridoux, F. Vrtovsnik, J.L. Preud'homme, M. Cogne, and G. Touchard
Mutational Analysis in Murine Models for Myeloma-Associated Fanconi's Syndrome or Cast Myeloma Nephropathy
Blood,
November 15, 1999;
94(10):
3559 - 3566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Decourt, G. Touchard, J.-L. Preud'homme, R. Vidal, H. Beaufils, M.-C. Diemert, and M. Cogne
Complete Primary Sequences of Two {lambda} Immunoglobulin Light Chains in Myelomas with Nonamyloid (Randall-Type) Light Chain Deposition Disease
Am. J. Pathol.,
July 1, 1998;
153(1):
313 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|